Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

Proinsulin-transferrin (ProINS-Tf) fusion protein was evaluated for its in vivo pharmacokinetics, efficacy, and mechanism. Our previous studies have shown that ProINS-Tf was converted to active ...

Endocytosis and recycling control the uptake and retrieval of various materials in eukaryotic cells. Mammalian cells have ...

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

PORTLAND, HI, UNITED STATES, September 17, 2024 /EINPresswire / -- The global protein therapeutics <a target=_blank href= ...

IBI363 has earned fast track designation from the FDA for the treatment of previously treated unresectable advanced melanoma.

Because the aim of the experiment is to compare GST with a GST fusion protein, it is necessary to prepare enough precleared lysate for each reaction. Efficient mixing of reagents is the key to ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

We demonstrate a method for purification of soluble fusion proteins incorporating an ELP tag. Advantages of this method, termed "inverse transition cycling," include technical simplicity ...

Green Fusion (Website), the “pure” vegan and vegetarian fine dining restaurant in Ridgewood, is making some big changes. They ...

The menu at Mint & Martini Indian Cuisine embraces both Indian cuisine and Italian. This unlikely culinary combination has ...